Navigation Links
That's Nice LLC Launches Nice Insight Marketing Intelligence for CRAMs With Its Pharma & Biotech Outsourcing Survey
Date:2/2/2011

NEW YORK, Feb. 2, 2011 /PRNewswire/ -- That's Nice LLC, a brand and marketing management agency serving pharmaceutical and biotech markets for 14 years, announced today that its Nice Insight Pharmaceutical & Biotechnology Outsourcing Survey will launch on February 16, 2011.

That's Nice serves 300 marketing clients in the materials science and life science industries. The company is investing $2.5 million into its new Nice Insight brand, encompassing the design and deployment of the Pharmaceutical & Biotechnology Outsourcing Survey that will solicit input from up to 40,000 respected industry professionals, and collection and analysis of visual and messaging strategies employed by 400+ CRAMs companies.

This degree of commitment and investment will deliver two robust core product offerings, called 'Marcom Tracker' and 'Brand Index,' which will provide a level of marketing intelligence not currently available to companies in the Contract Research & Manufacturing (CRAMs) sector. The products will also benefit any company seeking to partner with the industry's innovators and developers.

Victor Coker, Director of Business Intelligence, said, "CRAMs and innovator companies need a practical and personalized evaluation of the market to enable them to more effectively align their communications and services with their potential partners. This is the only way to improve collaborations and enhance the prospective pipeline for life-changing drugs. While working in CRAMs, I was unable to access intelligence in this depth and format, so we're very excited about Nice Insight."

The 40,000 industry professionals canvassed in the Pharmaceutical & Biotechnology Outsourcing Survey represent Big Pharma, Mid-size Pharma, Virtual and Emerging Companies, and Small Biotechs. The Brand Index product consequently offers focused insight into innovator & investor perceptions of CRAMs providers and highlights the current needs of potential resear
'/>"/>

SOURCE That's Nice LLC
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine technology :

1. Iomai Launches Phase 1/2 Safety Study of Dose-Sparing Patch for Use With Pandemic Influenza Vaccine
2. Keeping the Data Center Clean: ATEN Launches Industry-First KVM Switches with Antimicrobial Nanocoating to Protect Products from Bacteria Surviving on Surfaces
3. Cell Therapeutics, Inc. (CTI) Launches Phase III Study for Pixantrone in Relapsed Indolent Non-Hodgkins Lymphoma (NHL)
4. Tengion Launches Second Phase 2 Clinical Trial of Regenerated Human Organ
5. Strategic Diagnostics Launches Initial Oncology-Targeted Antibody Reagent Catalog
6. deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
7. Premier Micronutrient Launches Supplement for Hearing Health
8. deCODE Launches deCODE MI(TM) -- A Test for a Major Genetic Risk Factor for Early-onset Heart Attack
9. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
10. Seal Shield Launches Worlds First Antibacterial, Dishwasher Safe Keyboard and Mouse for Infection Control
11. PositiveFriends.com Launches STD Social Networking Site Balancing Dating with Online Support Features
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013 /PRNewswire/ ... VRX ) (TSX: VRX) ... directors nominated at its 2013 annual ... results of the vote for the ... below:  NameForWithheldRonald H. Farmer235,731,9341,964,748Robert A. Ingram233,865,8763,830,806Theo ...
(Date:5/21/2013)... Massachusetts , 21. Mai 2013 /PRNewswire/ ... („OSI"), die die Firmen OMNIlife science® Inc., Enztec ... zählt, hat zwei neue, erfahrene Mitglieder in ... , eine erfahrene Führungspersönlichkeit aus der ... David Johnson , anerkannter ...
(Date:5/21/2013)... , 21 de mayo de 2013 La ... compañías filiales incluyen OMNIlife science®, Inc., Enztec, Ltd. y ... para su junta. Guy Mayer, un ejecutivo ortopédico experimentado, ... David Johnson , un experto refutado ... Antes de unirse a OSI como presidente ...
Breaking Medicine Technology:Valeant Pharmaceuticals Announces 2013 Annual Meeting Results 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 2Orthopaedic Synergy Inc. meldet bedeutenden Zuwachs im Vorstand 3Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 2Orthopaedic Synergy, Inc. anuncia nuevas incorporaciones a la junta directiva 3
... improvement solutions provider GP Strategies Corporation (NYSE: ... ended March 31, 2012. Overview of First Quarter ... quarter of 2012 compared to $64.3 million for first quarter of ... of 2012 compared to $4.3 million for first quarter of 2011 ...
... 2012 Valeant Pharmaceuticals International, Inc. (NYSE: ... that Valeant has agreed to acquire certain assets ... company focused on skincare products, for approximately $64 ... future revenue targets.  University Medical,s main brand is ...
Cached Medicine Technology:GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 2GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 3GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 4GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 5GP Strategies Reports Strong First Quarter 2012 EPS of $0.23 6Valeant Pharmaceuticals Agrees To Acquire AcneFree And Certain Assets From University Medical 2
(Date:5/21/2013)... Boca Raton, Fla. (PRWEB) May 21, 2013 ... TV program distributed on cable networks and cable channels ... of new episodes on its YouTube channel. The producers ... profiles of companies in the shipping industry, the manufacturing ... program highlights pioneering medical facilities and medical practitioners in ...
(Date:5/21/2013)... MedMar Healing Center announces their participation in ... Bank. Twenty-eight businesses, including MedMar Healing Center, doctors, and clubs, ... goal is to raise food to help area kids who ... in recent years. , “We like being able to ... explains Douglas Chloupek of MedMar Healing Center. “Taking part in ...
(Date:5/21/2013)... (May 21, 2013) Research into genetic features of ... of Colorado School of Medicine may lead to improved ... paper published online by JAMA . , The ... survival in some cases of pulmonary fibrosis, a chronic ... As a result of the study, researchers may want ...
(Date:5/21/2013)... 2013 The nation’s first trial involving ... nearing its conclusion in Washington state court, Bernstein Liebhard ... yesterday, an attorney for the Plaintiffs compared Intuitive Surgical ... tie sales and services for its customers. ... control of surgeons, to keep control of hospitals and ...
(Date:5/21/2013)... May 21, 2013 Two executives from ... (SBG) will identify which strategies can be most effective ... care to the members who are taking them, in ... Inc., “How to Manage Specialty Drugs to Reduce ... are now the main driver for rising prescription drug ...
Breaking Medicine News(10 mins):Health News:In View hosted by Larry King Announces New Videos on its YouTube Channel 2Health News:San Jose Cannabis Club Helps Feed Hungry Children with Second Harvest Food Bank 2Health News:Researchers find genetic tie to improved survival time for pulmonary fibrosis 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 2Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 3Health News:Da Vinci Surgery Robot Lawsuit News: Bernstein Liebhard LLP Comments on Closing Arguments in Nation’s First Da Vinci Lawsuit Trial 4Health News:Consulting Firm Execs to Discuss Strategies for Effective Management of Specialty Drugs in AIS’s May 30 Webinar 2
... MONICA, Calif., Dec. 7 California,s,stem cell agency ... it was,rejecting 10 applications for research grants because ... billion stem cell program, the,Foundation for Taxpayer and ... consumer advocacy organization added that,to completely resolve the ...
... Dec. 7 Legendary blues artists Bobby,Rush and James ... the inaugural Mississippi Blues Marathon and Half-Marathon on Saturday,January ... & Mal,s, located at 200,South Commerce Street, in downtown ... scheduled to go on stage at 8:00 p.m., and ...
... for four blood proteins may provide a less-invasive follow-up for ... tomography (CT) scans, according to a new study led by ... a very high false positive rate when trying to discover ... Duke and lead investigator on the study. What that leads ...
... BioHorizons Implant Systems,Inc. relocated its global ... 44,000 square foot facility. The new facility, ... services, a newly,formed manufacturing facility and a ... surface treatment and packaging services., The ...
... 7 As of December 7,2007, Coshocton County Memorial ... nurses for a 3-year contract. As a result,bargaining unit ... strike,and maintain a picket line starting at 7:00 a.m. ... highly developed skills and extensive,education. Each and every day ...
... BAN(R)/Seventeen.com Stress Relief Survey are in, NEW YORK, Dec. ... and messy breakups anymore. The fast-paced world we live in ... people, especially young,women, face. This trend can be seen in ... what are some of the factors that contribute,to this new ...
Cached Medicine News:Health News:Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say 2Health News:Stem Cell Institute Correct in Rejecting Applications Over Conflicts of Interest; Institutions, Board Members Involved Must Be Identified, Consumer Advocates Say 3Health News:Study points to possibility of blood test to detect lung cancer 2Health News:BioHorizons Expands to New 44,000 Square Foot Facility 2Health News:Coshocton County Memorial Hospital RNs to Strike Despite Hospital's Claim of Financial Hardship 2Health News:Coshocton County Memorial Hospital RNs to Strike Despite Hospital's Claim of Financial Hardship 3Health News:What Stresses Teens Out 2Health News:What Stresses Teens Out 3
Liquichek Reticulocyte Control is a human whole blood based control designed to monitor manual and automated methods for counting reticulocytes. Assayed values are provided at three clinically signif...
Liquichek Hematology Control (C) is an assayed hematology control for evaluating the performance of Coulter hematology instruments with complete CBC and VCS 5-part differential technology....
... Liquichek Lipids Control is ... product that provides the ... analyte levels for lipids ... C-Reactive Protein in levels ...
... Control (Human) provides a comprehensive analyte ... and CO2. It requires no special ... major instruments and methodologies. Available in ... sizes (10 mL fill size available ...
Medicine Products: